companydata.dkVarCT Diagnostics ApS: Financial statements 2024
CVR: 38733567
VarCT Diagnostics ApS (CVR 38733567) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,425,482 and a net result of DKK 779,245 compared with DKK -1,644,799 the year before. That is an increase of 674.4% compared with the year before. Equity amounted to DKK 4,199,757. The solvency ratio was 74.1%. The company had 5 employees in the financial year.
- Gross Profit
- 3,425,482 kr.
- Profit/Loss
- 779,245 kr.
- Equity
- 4,199,757 kr.
- Total Assets
- 5,668,349 kr.
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 3.4 mio. | 779 t. | 4.2 mio. | 5 |
| 2023 | - | 442 t. | -1.6 mio. | 3.4 mio. | 5 |
| 2022 | - | 89 t. | -1.9 mio. | 5.1 mio. | 4 |
| 2021 | - | -483 t. | -1.7 mio. | 7 mio. | 2 |
| 2020 | - | 1.2 mio. | -761 t. | 8.7 mio. | 3 |
How creditworthy is VarCT Diagnostics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
VarCT Diagnostics ApS has published its annual report for 2023. Gross profit came to DKK 442,364, and the net result was DKK -1,644,799.
About VarCT Diagnostics ApS
VarCT Diagnostics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali El-Salanti and Mads Daugaard. The company is owned by VAR2 PHARMACEUTICALS ApS and Sitour Management m.b.H.. The company has 4 employees. In 2025, the company reported a gross profit of DKK 176,862 and a net result of DKK -1,961,493 compared with DKK 779,245 the year before. Equity amounted to DKK 2,238,264.